期刊文献+

以溶血性贫血为首发表现的肝豆状核变性伴鱼鳞癣1例报告 被引量:1

Hemolytic anemia as the first manifestation in hepatolenticular degeneration combined with ichthyosis:a case report
下载PDF
导出
摘要 目的探讨以溶血性贫血为首发表现的肝豆状核变性(HLD)的临床特点及HLD与鱼鳞癣之间的关系。方法回顾分析1例以溶血性贫血为首发表现的肝豆状核变性伴鱼鳞癣患儿的临床表现、发病经过及诊断和治疗过程。结果患儿,女,10岁,临床以乏力、黄疸为首发症状,入院5 d后出现腹胀,进行性加重。网织红细胞8.5%,Coombs试验阴性,角膜出现K-F环,全腹CT平扫示胸腔及腹腔积液,肝脏异常物质沉积,脾大。ATP 7 B及TGM 1基因突变,均位于第14对染色体上。确诊肝豆状核变性合并鱼鳞癣。给予驱铜、阻止铜吸收及口服维A酸等对症支持治疗,病情缓解。结论以溶血性贫血首发的HLD,且合并鱼鳞癣极其少见。 Objective To explore the clinical features of hepatolenticular degeneration (HLD) with hemolytic anemia as the first manifestation, and its relationship with ichthyosis. Method The clinical manifestations, course, diagnosis, and treatment of HLD combined with ichthyosis in one child who presented with hemolytic anemia as the frst manifestation, were retrospectively analyzed. Results In ten-year-old girl, the frst symptom was fatigue and jaundice, and then progressed to abdominal distension 5 days after admission. The reticulocyte percentage was 8.5%. Coombs test was negative. The K-F rings appeared on the cornea. The CT scan of Abdomen showed pleural and peritoneal effusion, abnormal substance deposition in liver and splenomegaly. There were mutations in ATP7B and TGM1 genes, both of which were located on fourteenth of chromosomes. The diagnosis of HLD combined with ichthyosis was confrmed. After symptomatic and supportive treatments such as removal of copper, prevention of the copper absorption and supplement of vitamin A, the disease was brought to remission. Conclusion HLD with hemolytic anemia as the frst manifestation, combined with ichthyosis was extremely rare.
作者 孙瑞丽 朱淑霞 张燕燕 王翠翠 王行健 SUN Ruili ZHU Shuxia ZHANG Yanyan WANG Cuicui WANG Xingjian(Department of Pediatrics, Affliated Hospital of Binzhou Medical College, Binzhou 256600, Shandong, Chin)
出处 《临床儿科杂志》 CAS CSCD 北大核心 2016年第10期734-736,共3页 Journal of Clinical Pediatrics
关键词 肝豆状核变性 溶血性贫血 鱼鳞癣 hepatolenticular degeneration hemolytic anemia ichthyosis
  • 相关文献

参考文献2

二级参考文献25

  • 1梁秀龄,陈曦,李洵桦,黄丽,石铸,汤其强.肝豆状核变性临床若干问题[J].中华神经科杂志,2005,38(1):57-59. 被引量:54
  • 2Ala A, Walker AP, Ashkan K, et al. Wilson's disease. Lancet, 2007, 369:397-405.
  • 3Figus A, Angius A, Loudianos G, et al. Molecular pathology and haplotype analysis of Wilson disease in Mediterranean populations. Am J Hum Genet, 1995, 57: 1318-1324.
  • 4Roberts EA, Schilsky ML; Division Gastroenterology and Nutrition. A practice guideline on Wilson disease. Hepatology, 2003, 37 : 1475-1492.
  • 5Wilson DC ,Phillips M J, Cox DW, et al. Severe hepatic Wilson's disease in preschool-aged children. J Pediatr, 2000, 137: 719- 722.
  • 6Ala A, Borjigin J, Rochwarger A, et al. Wilson disease in septuagenarian siblings : Raising the bar for diagnosis. Hepatology, 2005, 41:668-670.
  • 7Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int, 2003,23 : 139-142.
  • 8Sinha S ,Taly AB. Withdrawal of peniciUamine from zinc sulphatepenicillamine maintance therapy in Wilson's disease : promising, safe and cheap. J Neurol Sci, 2008,264: 129-132.
  • 9Brewer GJ, Hedera P, Khin KJ, et al. Treatment of Wilson disease with ammonium tetrathiomolybdate: Ⅲ. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy. Arch Neurol, 2003,60: 379-385.
  • 10Brewer GJ. Novel therapeutic approaches to the treatment of Wilson's disease. Expert Opin Pharmacother, 2006, 7: 317-324.

共引文献261

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部